The objective of this study was to assess the efficacy of a dual test blood @entity413 / @entity9208 home monitoring system to screen individuals in the workplace for poor glycemic control. Screening values qualifying individuals for 90 days of additional monitoring were as follows: fasting blood @entity413 > or =126 mg/dL, casual blood @entity413 > or =140 mg/dL, and/or @entity9208 <310 micromol/L. Subjects with positive values were provided access to classroom instruction by a Certified @entity6 Educator. The population consisted of 100 males and 177 females, ages 22-71 years, mean 49.7 years, with 12 males and 22 females reporting @entity6 . Their ethnic backgrounds were 17.7% African American, 0.4% Asian, 1.8% Hispanic, 0.4% mixed, and 79.8% Caucasian reflecting the general United States population. A total of 26 males and 27 females had results indicating poor glycemic control. Of the known individuals with @entity6 , seven of 12 males and 15 of 22 females had positive results. More males than females were unaware of their potential for @entity6 but of those previously diagnosed with @entity6 more females than males had poor glycemic control. A total of 31 subjects tested positive for blood @entity413 , 39 tested positive for @entity9208 , indicating a 15.1% (p < 0.005) improvement in detection chances with @entity9208 . Cost per subject including equipment, supplies, and labor was  18.13. Study results indicate that the addition of a @entity9208 test improves screening accuracy for large groups of @entity1 while retaining ease of use and affordability.

Dual test XXXX screening project: screening for poor glycemic control in a large workplace population.

@entity1 :: ('9606', 'Species') :: ['people'] @entity413 :: ('MESH:D005947', 'Chemical') :: ['glucose'] @entity6 :: ('MESH:D003920', 'Disease') :: ['Diabetes', 'diabetes'] @entity9208 :: ('MESH:D019270', 'Chemical') :: ['fructosamine']
@entity6 :: (MESH:D003920,Disease) :: ['diabetes']
